CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF)
CUSIP: G1933S101
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Ordinary Shares
- Shares outstanding
- 35,821,764
- Total 13F shares
- 252,002
- Share change
- -25,702
- Total reported value
- $909,576
- Price per share
- $3.61
- Number of holders
- 20
- Value change
- -$261,433
- Number of buys
- 9
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP G1933S101?
CUSIP G1933S101 identifies CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G1933S101:
Top shareholders of CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Wellington Shields Capital Management, LLC |
13F
|
Company |
0.37%
|
133,146
|
$953,325 | — | 31 Dec 2023 | |
| Wellington Shields & Co., LLC |
13F
|
Company |
0.12%
|
43,091
|
$308,532 | — | 31 Dec 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.08%
|
29,100
|
$208,000 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
22,221
|
$161,546 | — | 31 Dec 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.06%
|
19,743
|
$143,532 | — | 31 Dec 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
12,916
|
$93,899 | — | 31 Dec 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.04%
|
12,538
|
$89,772 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,453
|
$10,403 | — | 31 Dec 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,222
|
$8,750 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
296
|
$2,119 | — | 31 Dec 2023 | |
| WEST PACES ADVISORS INC. |
13F
|
Company |
0%
|
100
|
$716 | — | 31 Dec 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
25
|
$182 | — | 31 Dec 2023 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
13
|
$93 | — | 31 Dec 2023 | |
| Colonial Trust Co / SC |
13F
|
Company |
0%
|
11
|
$79 | — | 31 Dec 2023 | |
| Kozak & Associates, Inc. |
13F
|
Company |
0%
|
10
|
$54 | — | 31 Dec 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
6
|
$43 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
3
|
$21 | — | 31 Dec 2023 |
Institutional Holders of CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF) as of Q1 2024
As of 31 Mar 2024,
CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
252,002 shares.
The largest 10 holders included
Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, HOWLAND CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, WELLS FARGO & COMPANY/MN, Catalyst Funds Management Pty Ltd, MORGAN STANLEY, SIMPLEX TRADING, LLC, and FMR LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
17
Q1 2024 holders
20
Holder diff
3
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.